Okta, Immunic, FirstEnergy, ADC, GNL Trending With Analysts

Analysts are intrested in these 5 stocks: ( (OKTA) ), ( (IMUX) ), ( (FE) ), ( (ADC) ) and ( (GNL) ). Here is a breakdown of their recent ratings and the rationale behind them.

Okta is creeping back onto analysts’ buy lists as confidence grows that its identity “crisis” is turning into an AI-driven catalyst. Raymond James’ Adam Tindle has upgraded OKTA to Buy with an $85 target, arguing that the worst of the renewal headwinds is behind it and that revenue growth could reaccelerate above 10% in FY27 as key metrics stabilize.

The bigger story is structural: as enterprises move AI agents from experiments into production, each bot will need its own secure identity, expanding Okta’s addressable market beyond human workers. With the stock trading around 3x EV/revenue and a low double‑digit free‑cash‑flow multiple, Tindle sees a roughly 3:1 upside/downside skew if execution improves and the market starts valuing OKTA closer to faster-growing peers.

Immunic is emerging as a speculative biotech play that’s catching fresh attention from Wall Street. Stifel’s Paul Matteis launched coverage on IMUX with a Buy rating and a $2.50 target, betting that its lead drug vidoflimus calcium (“VidoCa”) has a high chance of success in late‑stage trials for relapsing multiple sclerosis, thanks to a cleaner safety profile versus older pill Aubagio.

Matteis assigns an 80% probability of Phase 3 success and highlights that key opinion leaders see room for a safer oral option even in an MS market dominated by heavyweight Ocrevus and crowded with generics. If VidoCa also delivers on a potential neuroprotection angle and extends into progressive MS, upside to Immunic’s revenue outlook could be significant from today’s beaten‑down valuation.

FirstEnergy is drawing cautious interest as a steady, regulated utility positioned in the middle of the U.S. power grid’s data-center boom. Analyst Shelby Tucker has initiated coverage of FE at Hold with a $56 target, forecasting about 8% EPS growth and roughly 10% rate base expansion, driven by ongoing investments in its service territories.

The key theme is transmission: FE’s footprint stretches from generation-heavy western PJM to high-demand eastern hubs, making it a critical conduit as data centers push grid limits. Yet Tucker warns that structural regulatory risk in PJM, ongoing reforms at FERC, and upcoming rate cases could cap upside, justifying a market‑level valuation based on a 2027 P/E of 18.1x.

Agree Realty, long viewed as a defensive, high-quality net-lease REIT, is losing some of its shine in analysts’ relative rankings. BMO’s Eric Borden has downgraded ADC to Hold (Market Perform) while keeping an $86 target, citing limited earnings lift from acquisitions, below-peer cash NOI yields, and a valuation that already bakes in its premium balance sheet and investment‑grade tenant base.

Borden sees more compelling upside in peer NETSTREIT, which offers similar portfolio quality and growth at a cheaper multiple. While ADC still plans sizable investments of $1.4–$1.6 billion in 2026, Borden estimates even a $400 million guidance bump would add just a penny to AFFO per share, leaving the stock more of a safe haven than a high‑octane growth story.

Global Net Lease has been one of the quiet comeback stories in the net-lease space, but analysts now think the easy gains are behind it. BMO’s John Kim has cut GNL to Hold (Market Perform) with a steady $10 target, noting that the stock has already delivered nearly 40% total return over the last year and over 80% in two years while its AFFO multiple has more than doubled since 2022.

After $3.4 billion of non-core asset sales, leverage is improved and the discount to peers has narrowed, but Kim expects a slower grind from here as GNL still needs to reduce debt and shrink a sizable office exposure at potentially dilutive prices. With its key McLaren Campus sale now completed and a 2026 leverage goal still above sector averages, GNL may keep repricing higher, just at a more measured pace than its recent sprint.